Anthony Caggiano

539 total citations · 1 hit paper
15 papers, 357 citations indexed

About

Anthony Caggiano is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Anthony Caggiano has authored 15 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Anthony Caggiano's work include Cardiac Fibrosis and Remodeling (3 papers), Ion channel regulation and function (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Anthony Caggiano is often cited by papers focused on Cardiac Fibrosis and Remodeling (3 papers), Ion channel regulation and function (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Anthony Caggiano collaborates with scholars based in United States, United Kingdom and Sweden. Anthony Caggiano's co-authors include Douglas B. Sawyer, Lon S. Schneider, Kaj Blennow, Martí Colom‐Cadena, Michael Grundman, Nicholas J. Izzo, Christopher H. van Dyck, John Harrison, Philip Scheltens and Steven T. DeKosky and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Anthony Caggiano

15 papers receiving 345 citations

Hit Papers

The clinical promise of biomarkers of synapse damage or l... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony Caggiano United States 8 134 112 82 63 48 15 357
Jia Zou China 12 100 0.7× 168 1.5× 81 1.0× 66 1.0× 26 0.5× 19 412
Dustin Chernick United States 8 137 1.0× 92 0.8× 53 0.6× 47 0.7× 14 0.3× 10 341
Purnima P. Desai United States 8 139 1.0× 126 1.1× 73 0.9× 29 0.5× 16 0.3× 8 349
Nipun Chopra United States 8 221 1.6× 199 1.8× 51 0.6× 59 0.9× 21 0.4× 14 467
Crystal Acosta Canada 9 137 1.0× 125 1.1× 106 1.3× 131 2.1× 17 0.4× 12 398
Yvonne Lewis United Kingdom 10 76 0.6× 160 1.4× 117 1.4× 67 1.1× 11 0.2× 18 411
Nina Hoque Japan 7 115 0.9× 81 0.7× 76 0.9× 34 0.5× 34 0.7× 11 258
Lars Schack Kruse Denmark 11 66 0.5× 195 1.7× 30 0.4× 68 1.1× 40 0.8× 20 416
Jay R Vargas United States 6 70 0.5× 128 1.1× 153 1.9× 50 0.8× 41 0.9× 9 350
Hanjun Guan United States 9 227 1.7× 150 1.3× 129 1.6× 46 0.7× 20 0.4× 12 407

Countries citing papers authored by Anthony Caggiano

Since Specialization
Citations

This map shows the geographic impact of Anthony Caggiano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Caggiano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Caggiano more than expected).

Fields of papers citing papers by Anthony Caggiano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Caggiano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Caggiano. The network helps show where Anthony Caggiano may publish in the future.

Co-authorship network of co-authors of Anthony Caggiano

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Caggiano. A scholar is included among the top collaborators of Anthony Caggiano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Caggiano. Anthony Caggiano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rehak, Courtney, et al.. (2021). Unbiased omics analyses of the sigma-2 antagonist CT1812 in age-related diseases and models. Investigative Ophthalmology & Visual Science. 62(8). 267–267. 2 indexed citations
2.
Colom‐Cadena, Martí, Tara L. Spires‐Jones, Henrik Zetterberg, et al.. (2020). The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease. Alzheimer s Research & Therapy. 12(1). 21–21. 208 indexed citations breakdown →
3.
Lenihan, Daniel J., Michael Koren, Andrew Eisen, & Anthony Caggiano. (2018). SUSTAINED IMPROVEMENT OF LEFT VENTRICULAR EJECTION FRACTION WITH INTRAVENOUS CIMAGLERMIN IN PATIENTS WITH SYMPTOMATIC SYSTOLIC DYSFUNCTION. Journal of the American College of Cardiology. 71(11). A667–A667. 1 indexed citations
4.
Howell, Brett A., Donald Button, Anthony Caggiano, et al.. (2017). Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials. Clinical Pharmacology & Therapeutics. 102(6). 961–969. 30 indexed citations
5.
Iaci, Jennifer F., Tom J. Parry, Zhihong Huang, et al.. (2015). An optimized dosing regimen of cimaglermin (neuregulin 1β3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in rats. Journal of Neuroscience Research. 94(3). 253–265. 14 indexed citations
6.
Brittain, Evan L., James A.S. Muldowney, Carrie Geisberg, et al.. (2013). EVALUATION OF CARDIAC FUNCTION IN SYMPTOMATIC HEART FAILURE PATIENTS IN A SINGLE INFUSION, PHASE 1, DOSE ESCALATION STUDY OF GLIAL GROWTH FACTOR 2. Journal of the American College of Cardiology. 61(10). E715–E715. 5 indexed citations
7.
Caggiano, Anthony & Andrew R. Blight. (2013). In vitroevaluation of the effects of 4-aminopyridine on cytochrome P450 enzymes. PubMed. 2(1). 106–116. 4 indexed citations
8.
Lenihan, Daniel J., Sarah Anderson, Carrie Geisberg, et al.. (2013). SAFETY AND TOLERABILITY OF GLIAL GROWTH FACTOR 2 IN PATIENTS WITH CHRONIC HEART FAILURE: A PHASE I SINGLE DOSE ESCALATION STUDY. Journal of the American College of Cardiology. 61(10). E707–E707. 7 indexed citations
9.
Caggiano, Anthony, Andrew R. Blight, & Tom J. Parry. (2013). Effects of dalfampridine and its metabolites on cloned human potassium channels Kv1.1, Kv1.2, and Kv1.4 expressed in human embryonic kidney cells. PubMed. 2(1). 58–66. 3 indexed citations
10.
Caggiano, Anthony, Andrew R. Blight, & Tom J. Parry. (2013). Identification of metabolites of dalfampridine (4-aminopyridine) in dog and rat. PubMed. 2(1). 72–80. 5 indexed citations
11.
12.
Williams, Phillip, et al.. (2011). Abstract 15531: Neuregulin-1{beta} Improves Cardiac Remodeling After MI in Swine. Circulation. 124. 2 indexed citations
13.
Sawyer, Douglas B. & Anthony Caggiano. (2011). Neuregulin-1β for the treatment of systolic heart failure. Journal of Molecular and Cellular Cardiology. 51(4). 501–505. 36 indexed citations
14.
Heller, Debra S., et al.. (2003). Aggressive Angiomyxoma of the Space of Retzius: A Case Report. Journal of Lower Genital Tract Disease. 7(4). 304–306. 7 indexed citations
15.
Caggiano, Anthony & G L Powell. (1979). Regulation of enzymes by fatty acyl coenzyme A. Site-specific binding of fatty acyl coenzyme A by citrate synthase–a spin-labeling study.. Journal of Biological Chemistry. 254(8). 2800–2806. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026